We are a team of dedicated biopharmaceutical professionals, each with decades of experience, all committed to making a difference in the lives of everyday people through the development of affordable, easy-to-use drug products addressing unmet medical needs.
We have developed a new platform technology designed to make it easy for anyone to administer urgently needed drugs, without training or prior experience, when patients are unable to treat themselves and time is of the essence.
Bruce has been an entrepreneur
and senior manager in biotech for
more than 30 years, with
experience at Baxter, Monitor
Group, Sequus, Acacia, GeneSoft,
VitaPath and Iconic. He's currently
a venture partner with Xeraya
Capital. Bruce has a BA and MA
from Tufts and an MBA from
Harvard Business School..
Nicole is an experienced operator
and former cell biologist and
neuroscientist, with roles as
founding managing director of
BioLabs@NYULangone and CEO
of Stellate Therapeutics. She is
a graduate of UChicago, earned
her PhD at University College
London and completed her
post-doc at Mount Sinai.
Ed brings more than 30 years of experience in biopharmaceuticals and clinical and regulatory affairs, with experience at Roche, Sequus, Alza, J&J and Velocity. He completed his MD at Georgetown Medical and fellowships at NYU and Memorial Sloan Kettering.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.